BERTUZZO, VALENTINA ROSA
 Distribuzione geografica
Continente #
NA - Nord America 2.751
EU - Europa 1.852
AS - Asia 1.106
AF - Africa 173
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.894
Nazione #
US - Stati Uniti d'America 2.742
GB - Regno Unito 405
IT - Italia 382
SE - Svezia 348
VN - Vietnam 309
SG - Singapore 305
CN - Cina 285
DE - Germania 243
IN - India 132
IE - Irlanda 102
FR - Francia 62
RU - Federazione Russa 62
TG - Togo 59
CI - Costa d'Avorio 57
UA - Ucraina 50
CH - Svizzera 44
ZA - Sudafrica 33
FI - Finlandia 32
EE - Estonia 27
BG - Bulgaria 26
JO - Giordania 23
BE - Belgio 19
NG - Nigeria 19
TR - Turchia 13
ES - Italia 12
NL - Olanda 10
CA - Canada 9
MK - Macedonia 7
ID - Indonesia 6
PK - Pakistan 6
PH - Filippine 5
BR - Brasile 4
CL - Cile 4
HK - Hong Kong 4
UZ - Uzbekistan 4
AT - Austria 3
GR - Grecia 3
IR - Iran 3
PL - Polonia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AU - Australia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
JP - Giappone 2
LK - Sri Lanka 2
MY - Malesia 2
NO - Norvegia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
EU - Europa 1
HR - Croazia 1
PT - Portogallo 1
Totale 5.894
Città #
Southend 349
Chandler 330
Singapore 275
Fairfield 274
Dong Ket 239
Houston 195
Ashburn 163
Woodbridge 146
Wilmington 134
Ann Arbor 120
Princeton 117
Cambridge 113
Santa Clara 107
Seattle 105
Dublin 102
Boardman 82
Bologna 72
Lomé 59
Abidjan 57
Bern 39
Westminster 39
Berlin 34
Helsinki 31
Nanjing 29
New York 29
Florence 27
Medford 26
Sofia 26
Jinan 25
Amman 23
Bremen 23
Jacksonville 20
Padova 20
Abeokuta 19
Brussels 19
Redmond 19
Shenyang 17
Turin 17
Saint Petersburg 15
Rome 14
Beijing 13
Falls Church 13
Milan 13
San Diego 12
Bursa 11
Des Moines 11
Los Angeles 11
Bühl 10
Hyderabad 10
Portland 10
Tianjin 10
Changsha 9
Nanchang 9
Olalla 9
Dearborn 8
Hebei 8
Nottingham 8
Phoenix 8
Pune 8
Shanghai 8
Jiaxing 7
Jakarta 6
Ningbo 6
San Francisco 6
Taizhou 6
Toronto 6
Zhengzhou 6
Frattamaggiore 5
Fremont 5
Haikou 5
Kannur 5
Mülheim 5
Norwalk 5
Wenzhou 5
Casalecchio di Reno 4
Fort Worth 4
Fuzhou 4
Hong Kong 4
Kunming 4
Lausanne 4
Madrid 4
Paris 4
Reggio Emilia 4
Rimini 4
Shijiazhuang 4
Siena 4
Skopje 4
Wuhan 4
Amsterdam 3
Andover 3
Boydton 3
Cattolica 3
Chicago 3
Esslingen am Neckar 3
Ferrara 3
Frankfurt Am Main 3
Genoa 3
Hangzhou 3
Leawood 3
Mahé 3
Totale 3.919
Nome #
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 237
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 224
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 181
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 166
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 153
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 151
Impact of preoperative infection on outcome after liver transplantation 140
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 138
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 138
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 137
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 135
null 135
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 123
Survival Benefit After Liver Transplantation: A Single European Center Experience 120
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 120
17. Other Malignant Primary Tumors of the Liver 118
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 115
Can Positive Resection Margin of Intra-hepatic Cholangiocarcinoma Still Provide a Survival Benefit over Systemic Chemotherapy? 115
null 115
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 115
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 111
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas 110
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 108
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 105
Combined abdominal transplantation: Liver-kidney 104
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 103
Comments to “Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases” 96
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 93
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 93
Reply 88
MATCH DONATORE-RICEVENTE NEL TRAPIANTO DI FEGATO: COME MIGLIORARE LA SOPRAVVIVENZA NEI PAZIENTI CON MELD ELEVATO NELL'ERA DEI DONATORI MARGINALI 87
Peritoneal seeding from appendiceal carcinoma: A case report and review of the literature 86
HCV ED ETA' AVANZATA SONO LIMITI SUPERABILI NELLA DONAZIONE DI RENE DA VIVENTE 86
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 84
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 84
Retransplantation (causes, outcome) 84
trapianto di rene da donatore marginale. Correlazione tra tipologia di lesione e prognosi a medio-lungo termine 84
Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis 83
Trapianto renale da donatore diabetico: modificazione dei pattern istologici di nefropatia diabetica 82
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 82
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. 79
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 78
DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC 78
Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus 77
Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial (Scientific Reports, (2020), 10, 1, (6063), 10.1038/s41598-020-62979-9) 76
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 76
IL RUOLO DELLA BIOPSIA RENALE NEL DONATORE DI RENE 75
LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS? 72
SHUNT PORTO-CAVALE IN TRAPIANTO SPLIT DI FEGATO: NECESSARIO SEMPRE CHIUDERLO E QUANDO? 69
RANDOMIZED TRIAL ON HYPOTHERMIC OXYGENATED PERFUSION VS STATIC COLD STORAGE IN LIVER TRANSPLANTATION FROM EXTENDED CRITERIA DONORS: INTERIM ANALYSIS 65
LA PERFUSIONE IPOTERMICA OSSIGENATA PUÒ PERMETTERE DI PROLUNGARE L'ISCHEMIA FREDDA NEL TRAPIANTO DI FEGATO CON ORGANI DA DONATORI ANZIANI? 62
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 60
PORTO-CAVAL SHUNT IN SPLIT LIVER TRASPLANTATION: IS THERE ANY TIME LIMIT TO CLOSE IT? 56
UN PECULIARE CASO DI “UNEXPECTED DONOR-DERIVED INFECTION” DA E.COLI ESBL MANIFESTATASI COME ARTERITE CON UGUALE EVOLUZIONE NEI RENI GEMELLI 51
STUDIO MONOCENTRICO RANDOMIZZATO SULLA PERFUSIONE IPOTERMICA OSSIGENATA VS. CONSERVAZIONE STATICA NEL TRAPIANTO DI FEGATO CON DONATORI CON CRITERI ESTESI: ANALISI AD INTERIM PRELIMINARE 50
TRAPIANTO EPATICO IN PAZIENTI CON STORIA DI AIDS: È POSSIBILE ALLARGARE LE INDICAZIONI ALL’INTERVENTO? 50
Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial 49
NEGATIVE PRESSURE TREATMENT OF WOUND AND ABDOMINAL INFECTIONS AFTER SOLID ORGAN TRASPLANTATION: BOLOGNA TRANSPLANT CENTER EXPERIENCE. 47
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 41
Alungamento dei vasi renali mediante allograft vascolari criopreservati: è possibile ottimizzare le problematiche tecniche nel trapianto da vivente con graft destri o vascolarizzazione anomala? 38
PHYSIOLOGICAL RECONSTRUCTIONS IN LIVER TRANSPLANTATION WITH NON-TUMORAL EXTENDED PORTAL VEIN THROMBOSIS: RESULTS AT TWO LARGE VOLUME CENTRES 30
Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up 24
The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation 17
Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant 15
Totale 6.064
Categoria #
all - tutte 17.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020699 0 0 0 0 0 116 124 135 159 65 54 46
2020/2021779 115 40 30 20 27 32 8 36 65 46 40 320
2021/20221.139 101 34 54 82 105 42 20 110 50 92 244 205
2022/20231.499 124 211 64 190 138 137 50 100 266 43 104 72
2023/2024433 46 94 37 37 29 86 11 15 7 24 19 28
2024/2025833 98 237 143 109 181 65 0 0 0 0 0 0
Totale 6.064